These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12619013)

  • 1. Nitric oxide and squamous carcinoma.
    Brennan PA
    J Oral Maxillofac Surg; 2003 Feb; 61(2):277. PubMed ID: 12619013
    [No Abstract]   [Full Text] [Related]  

  • 2. Does administration of isosorbide mononitrate affect cellular proliferation in oral squamous cell carcinoma? A prospective randomized clinical study.
    Downie IP; Umar T; Boote DJ; Mellor TK; Hoffman GR; Brennan PA
    J Oral Maxillofac Surg; 2004 Sep; 62(9):1064-8. PubMed ID: 15346355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception.
    Arteaga-Troncoso G; Villegas-Alvarado A; Belmont-Gomez A; Martinez-Herrera FJ; Villagrana-Zesati R; Guerra-Infante F
    BJOG; 2005 Dec; 112(12):1615-9. PubMed ID: 16305563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester.
    Bates CD; Nicoll AE; Mullen AB; Mackenzie F; Thomson AJ; Norman JE
    BJOG; 2003 Jan; 110(1):64-7. PubMed ID: 12504938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
    Demchenko EA; Berezina AV; Panov AV
    Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229
    [No Abstract]   [Full Text] [Related]  

  • 6. LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling.
    Paulis L; Simko F
    Hypertension; 2007 Dec; 50(6):1009-11. PubMed ID: 17984370
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks.
    Hidar S; Bouddebous M; Chaïeb A; Jerbi M; Bibi M; Khaïri H
    Arch Gynecol Obstet; 2005 Dec; 273(3):157-60. PubMed ID: 16041629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cardioprotective mechanism of exogenous nitric oxide: inhibition of Rho-associated kinase activity.
    Tanaka A; Node K
    Hypertens Res; 2015 Jul; 38(7):461-2. PubMed ID: 25902902
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficiency of various doses of topical isosorbide dinitrate in the treatment of chronic anal fissure and the long-term results: a prospective, randomized and controlled clinical trial.
    Kirkil C; Aygen E; Doğru O; Ilhan YS; Ayten R; Camci C; Göğebakan O
    Turk J Gastroenterol; 2012 Feb; 23(1):28-32. PubMed ID: 22505376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study.
    Ekerhovd E; Bullarbo M; Andersch B; Norström A
    Am J Obstet Gynecol; 2003 Dec; 189(6):1692-7. PubMed ID: 14710100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of long-term administration of isosorbide 5-mononitrate (Mononit), nitric oxide donor, on gallbladder emptying in patients with chronic stable angina].
    Hamankiewicz M; Kucio C; Czapla J; Wójcik P
    Wiad Lek; 2001; 54(3-4):137-42. PubMed ID: 11436678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of the blood oxygen transport function in patients with angina pectoris receiving treatment correcting the L-arginine-NO pathway].
    Zinchuk VV; Dobrodeĭ MA; Lis MA
    Fiziol Cheloveka; 2008; 34(2):136-8. PubMed ID: 18472585
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy.
    Thomson AJ; Lunan CB; Ledingham M; Howat RC; Cameron IT; Greer IA; Norman JE
    Lancet; 1998 Oct; 352(9134):1093-6. PubMed ID: 9798584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study.
    Bullarbo M; Orrskog ME; Andersch B; Granström L; Norström A; Ekerhovd E
    Am J Obstet Gynecol; 2007 Jan; 196(1):50.e1-5. PubMed ID: 17240231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term transdermal nitric oxide donor improves uteroplacental circulation in women with preeclampsia.
    Nakatsuka M; Takata M; Tada K; Asagiri K; Habara T; Noguchi S; Kudo T
    J Ultrasound Med; 2002 Aug; 21(8):831-6. PubMed ID: 12164565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sustained-release isosorbide dinitrate on post-prandial gastric emptying and gastroduodenal motility in healthy humans.
    Madsen JL; Rasmussen SL; Linnet J; Fuglsang S; Rumessen JJ
    J Int Med Res; 2004; 32(4):351-8. PubMed ID: 15303766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics.
    Nicoll AE; Mackenzie F; Greer IA; Norman JE
    Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of international study of quality of life of patients with stable angina treated with nitrates (IQOLAN)].
    Belenkov IuN; Chazova IE; Ratova LG; Dmitriev VV; Lebedeva NA; Pavlov VE; Bishele NA; Demura SA
    Kardiologiia; 2003; 43(9):4-7. PubMed ID: 14593363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: a randomized clinical trial.
    Tarhan F; Çelik O; Tosun Ç; Faydacı G; Eryıldırım B
    Urol Int; 2014; 93(1):17-21. PubMed ID: 24643055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2).
    Ekerhovd E; Weijdegård B; Brännström M; Mattsby-Baltzer I; Norström A
    Am J Obstet Gynecol; 2002 Apr; 186(4):745-50. PubMed ID: 11967501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.